Eloxx Pharmaceuticals initiates Phase 2 clinical trial for ELX-02

Six patients will be registered for the trial and will be treated with ELX-02 for four weeks with three rising dose levels. Eloxx Pharmaceuticals, Inc., an American biopharmaceutical company focused on the discovery and development of nove....

Squarex unveils Phase 2 results of SQX770 in recurrent herpes labialis

The study involved around 139 subjects who had reported four or more episodes of herpes labialis in the past 12 months Squarex, a clinical-stage pharmaceutical company has reportedly unveiled the positive results from a Phase 2 clinical tr....

Genentech’s Tecentriq® plus chemotherapy helps reduce risk of ABC

Data will be demonstrated at an upcoming medical meeting and shared with health authorities globally, including the U.S. FDA (Food and Drug Administration). Genentech, a subsidiary of the Roche Group, recently announced that the Phase III ....

SAIC partners with Espressive to offer next-gen IT solutions

Science Applications International Corp. (SAIC), an American IT firm that provides government services, is collaborating with Espressive, a California-based tech company that has developed AI technology for employee self-service needs.....

SABIC seemingly eager to partner Swiss chemical firm Clariant AG

The company is looking forward to joining Clariant after an improvement in market conditions. Saudi Basic Industries Corp. (SABIC), one of the largest public corporations in the Middle East and Saudi Arabia, has announced plans to partner ....

Brainscope declares to have surpassed primary endpoints in new study

Brainscope has announced the successful completion of its nearly five year research contract with United States Department of Defense. The contract worth $9.9 million was to support the development and validation of an objective marker syst....

Electric scooter rental Bird 'flies' above $2.3B funding valuation

Sequoia Capital may lead the upcoming funding round for Bird. It is expected to increase the startup's valuation by $0.2 billion. California based electric scooter startup- Bird Scooters has claimed to be valued at $2.5 billion in a r....

Oyster Point begins enrolment for Phase 3 ONSET-2 study of nasal spray

The trial is designed to assess the efficacy and safety of OC-01 for treating dry eye disease Reports confirm that Oyster Point Pharma, a clinical-stage biopharmaceutical company, has recently announced that the first subject has been enr....

Ligand buys AB Initio Biotherapeutics in a $12m cash transaction

Ligand is eligible to receive royalties and milestones depending on potential future sales Ligand Pharmaceuticals Incorporated, a biopharmaceutical company focused on acquiring and developing technology that help pharmaceutical companies t....

Canopy Rivers’ joint venture awarded Health Canada cultivation license

PharmHouse’s greenhouse facility in Ontario is reportedly one of the largest in the world Canopy Rivers Inc, Canopy Growth Corp’s venture capital arm, has recently announced that its PharmHouse Joint venture has secured a licen....